Among the non-synonymous mutations, 33 were present in both cell line and primary tumor, including truncating mutations of ARID1A and ARID1B genes and a cancer hotspot missense mutation of DICER1 gene (p.D1810Y). This evidence concerns the gene ARID1B and cancer.